Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program

American Journal of Clinical Nutrition

Volumn 68, Issue 4, 1998, Pages 778-785

  Parks, Elizabeth J ^a   German, J Bruce ^a   Davis, Paul A ^a   Frankel, Edwin N ^a   Kappagoda, C Tissa ^a   Rutledge, John C ^a   Hyson, Dianne A ^a   Schneeman, Barbara O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Atherosclerosis; Coronary artery disease; Fatty acid composition; LDL; Low density lipoprotein; Micronutrients; Oxidation; tocopherol, carotene

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID; TRACE ELEMENT;

ADULT; AEROBIC METABOLISM; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CATALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIETARY INTAKE; DISEASE PREDISPOSITION; EMOTIONAL STRESS; EXERCISE; FEMALE; GAS CHROMATOGRAPHY; HEALTH PROGRAM; HUMAN; LIPID PEROXIDATION; MALE; OXIDATION;

EID: 0031657309     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.4.778     Document Type: Article

References (45)

1. Witztum JL. The oxidative hypothesis of atherosclerosis. Lancet 1994;344:793-5.
2. Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992;339:1184-6.
3. Salonen JT, Nyyssonen K, Salonen R, et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 1997;95:840-5.
4. Shanmugasundaram KR, Srinivas K, Sundaram P, et al. Lipid peroxidation, antioxidant defenses and red-cell membrane changes in relation to coronary risk index and symptomatic coronary heart disease. J Cardiovasc Risk 1995;2:551-61.
5. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992;93:189-99.
6. de Graaf J, Haendriks JCM, Demacker PNM, Stalenhoef AFH. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriacylglycerolemic subjects, normalization after clofibrate treatment. Arterioscler Thromb 1993;13:712-9.
7. Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb 1994;14:557-66.
8. Reaven P, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not beta-carotene. Arterioscler Thromb 1993;13:590-600.
9. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation, a dose-response study. Arterioscler Thromb Vasc Biol 1995;15:190-8.
10. Princen HMG, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995;15:325-33.
11. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991;53(suppl):314S-21S.
12. Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not β-carotene in vivo protects low-density lipoprotein from lipid peroxidation in vitro. Arterioscler Thromb 1992;12:554-62.
13. Abbey M, Nestel PJ, Baghurst PA. Antioxidant vitamins and low-density-lipoprotein oxidation. Am J Clin Nutr 1993;58:525-32.
14. Lussier-Canan S, Dubreuil-Quidoz S, Roederer G, et al. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriacylglycerolemic patients. Arterioscler Thromb 1993; 13:1790-7.
15. Abbey M, Belling GB, Noakes M, Hirata F, Nestel PJ. Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr 1993;57:391-8.
16. Reaven P, Parthasarathy S, Grasse BJ, et al. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr 1991;54:701-6.
17. Wander RC, Du S-H, Ketchum SO, Rowe KE. Effects of interaction of RRR-α-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy. Am J Clin Nutr 1996;63:184-93.
18. Bonanome A, Biasia F, De Luca M, et al. n-3 Fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr 1996;63:261-6.
19. Frankel EN, Parks EJ, Xu R, Schneeman BO, Davis PA, German JB. Effect of n-3 fatty acid rich fish oil supplementation on the oxidation of low density lipoproteins. Lipids 1994;29:233-6.
20. Cominacini L, Garbin U, Pastorino AM, et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 1993;99:63-70.
21. Croft KD, Dimmitt SB, Moulton C, Beilin LJ. Low density lipoprotein composition and oxidizability in coronary disease - apparent favourable effect of beta-blockers. Atherosclerosis 1992;97:123-30.
22. Chiu HC, Jeng JR, Shieh SM. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease. Biochim Biophys Acta 1994;1225:200-8.
23. De Rijke YB, Vogelezang CJM, Van Berkel TJC, et al. Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients. Lancet 1992;340:858-59.
24. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129-33.
25. Schuler G, Hambrecht R, Schierf G, Niebauer J, Hauer K, Neumann J. Regular physical exercise and low-fat diet, effects on progression of coronary artery disease. Circulation 1992;86:1-11.
26. N-Squared Computing. Nutritionist III. Version 7.2. Silverton, OR: N-Squared Computing, 1991.
27. Bruce RA. Exercise testing of patients with coronary artery disease: principles and normal standards for evaluation. Ann Clin Res 1971;3:323-32.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
29. Bieri JG, Tolliver TJ, Catignani GL. Simultaneous determination of α-tocopherol and retinol in plasma and red cells by high pressure liquid chromatography. Am J Clin Nutr 1979;32:2143-9.
30. Driskell WJ. Measurements of vitamin A and vitamin E in human serum by high pressure liquid chromatography. J Chromatogr 1982;231:439-44.
31. Lowry OH, Rosenberg NJ, Farr AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem 1951;193:265-75.
32. Vakakis N, Redgrave TG, Small DM, Castelli WP. Cholesterol content of red blood cells and low-density lipoproteins in hypertriacylglycerolemia. Biochim Biophys Acta 1983;751:280-5.
33. Lepage G, Roy CE. Specific methylation of plasma nonesterified fatty acids in a one-step reaction. J Lipid Res 1988;29:227-35.
34. Berger A, German JB. Phospholipid fatty acid composition of various mouse tissues after feeding alpha-linolenate (18:3n-3) or eicosatrienoate (20:3n-3). Lipids 1990;25:473-80.
35. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470-5.
36. Phillips GB, Wille LE, Phillips ML. The phospholipid composition of human serum lipoprotein fractions separated by electrophoresis on agarose gel. Demonstration of a fraction with high lysolecithin content. Clin Chim Acta 1973;49:153-60.
37. Sata T, Havel RJ, Jones AL. Characterization of subfractions of triacylglycerol-rich lipoproteins separated by gel chromotography from blood plasma of normolipidemic and hyperlipidemic humans. J Lipid Res 1972;13:757-68.
38. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. In: Segrest JP, Albers JJ, eds. Methods in enzymology, plasma lipoproteins, part A. Preparation, structure, and molecular biology. Vol 128. Orlando, FL: Academic Press, 1986:417-31.
39. Deckelbaum RJ, Shipley GG, Small DM. Structure and interactions of lipids in human plasma low density lipoproteins. J Biol Chem 1977;252:744-54.
40. Atkinson D, Deckelbaum RJ, Small DM, Shipley GG. Structure of human plasma low-density lipoproteins: molecular organization of the central core. Proc Natl Acad Sci U S A 1977;74:1042-6.
41. Redgrave TG, Carlson LA. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriacylglycerolemic man. J Lipid Res 1979;20:217-29.
42. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
43. Frankel EN, German JB, Davis PA. Headspace gas chromatography to determine human low density lipoprotein oxidation. Lipids 1992;27:1047-51.
44. Abacus Concepts. StatView. Berkeley, CA: Abacus Concepts, Inc, 1992.
45. Anderson TJ, Meredith IT, Charbonneau F, et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996;93:1647-50.